Moisturising creams and preparations with peptides: formulation and scientific evidence

A peptide cream is a cosmetic formulation containing one or more peptide ingredients. At the same time, it is a complete moisturising system in which water, oils or other emollients, humectants, occlusive agents, emulsifiers, thickeners, preservatives, and other ingredients can influence the properties and effects of the product.

The word „peptide” therefore describes only part of the formulation. It does not automatically indicate the cause of every effect observed after applying the cream.

Some peptide-containing moisturisers have been evaluated in controlled human studies. Other publications look at several products used simultaneously or compare the participants' skin condition solely with the baseline value. Laboratory studies and ex vivo experiments, on the other hand, answer yet other questions.

These distinctions matter because they make it possible to determine whether a given result supports the effect of the finished cream, the peptide added to it, the proposed mechanism or the entire skincare routine.

When evaluating a peptide cream, therefore, it is worth asking a few specific questions:

• Which peptide is in the product?
• How was it chemically defined?
• What does the cream base contain?
• Has the peptide concentration been given?
• Was the cream compared with the same formulation without the peptide?
• Does the product also contain other active ingredients?
• Which exact parameter has changed?
• Was the result compared with the baseline or with the control group?
• How long was the product tested?
• Has peptide delivery to the skin been demonstrated if the proposed mechanism requires penetration into its living layers?

The answers to these questions provide a much better basis for evaluating a product than its consistency, price, number of ingredients, type of packaging, or the label „day cream” or „night cream”.

What is a peptide cream?

The cream is a carrier of the ingredients and at the same time part of the product's action

A cream is usually a semi-solid formulation containing aqueous and lipid ingredients forming an emulsion.

In an oil-in-water emulsion, the oil phase droplets are dispersed in a continuous aqueous phase. In a water-in-oil emulsion, the system is reversed. These differences can affect how the product spreads, the film it leaves behind, its occlusive properties, skin feel, evaporation, and the behaviour of ingredients within the formulation.

The term „moisturising preparation” describes primarily the function rather than one specific physical format. Creams, lotions, gels and certain serums can exhibit moisturising properties.

Therefore, a peptide moisturiser does not constitute a completely distinct scientific category from a standard moisturiser. It is a moisturising formulation that additionally contains one or more peptide ingredients. You can read more about the broader application of these molecules in cosmetics in the article Peptides in skincare.

Research on moisturisers indicates both the direct effect of their ingredients on the skin and the role of such formulations as carriers for other substances, including peptides. [1]

This dual function is important when interpreting peptide cream studies. The cream base itself can affect hydration, softness, lipid levels, water loss, surface smoothness of the skin, its elasticity and the visibility of fine lines.

Smoother or softer skin shortly after application does not necessarily mean a specific biological response triggered by the peptide. The formulation may alter hydration and surface skin properties, temporarily affect the visibility of fine lines, or change how light is reflected.

Such effects may be real and cosmetically significant, but in themselves they do not prove new collagen formation, dermal remodelling or any other deeper biological mechanism.

That is why it is worth keeping the basic distinction:

improvement resulting from the use of a ready-made cream ≠ effect whose source has been unequivocally identified as a peptide.

A peptide cream does not have a single standard „dose” of peptide

The term „peptide cream” does not imply a specific type, concentration, number or combination of peptides.

One product may contain a single, named synthetic peptide, whilst another several different peptides. Another still may contain a hydrolysate with peptide fragments or a patented blend. Yet another may combine peptides with retinoids, niacinamide, ceramides, hyaluronic acid, antioxidants, or plant extracts.

Products belonging to the same broad category can therefore differ greatly in chemical and functional terms.

Chemical modifications are also important. A palmitoylated peptide contains an attached group derived from a fatty acid. Other peptides may be acetylated, cyclised, conjugated with other molecules or form complexes with metals.

Such terms help to identify the ingredient, but they do not confirm the effectiveness of every cream containing a given type of peptide.

Evidence becomes significantly more informative when the study specifies both the peptide and the medium in which it was applied.

In a 12-week palmitoyl pentapeptide study, a moisturiser containing pal-KTTKS was compared with the same preparation without the peptide. The randomised, double-blind, split-face study involved 93 women aged 35–55 years. An improvement in selected wrinkle and fine line parameters was observed compared with the control formulation. [2]

Such a project is particularly valuable because a significant part of the formulation base was the same. The comparison was therefore similar to:

the same cream + peptide

regarding

of the same cream without the peptide.

This allows for a better assessment of the additional contribution of the peptide than a simple „before and after” study of the complex product.

However, the result still relates to a specific formulation, population, study duration and comparison used. It does not prove that every product described as a „peptide cream” will deliver the same result.

The peptide concentration is only one of the elements

Even if the peptide concentration is known, the value alone does not determine the product's efficacy.

The identity and sequence of the peptide, chemical modification, purity, stability, pH, solubility, type of vehicle, interactions with other ingredients, skin exposure, and delivery of the molecule to the biologically relevant site may also be important.

Therefore, it should not be assumed that two creams containing the same percentage of different peptides have equivalent biological activity. Even two products containing the same peptide at the same declared concentration may behave differently if they differ significantly in formulation.

A more useful scientific question is therefore not: „How much peptide is in the cream?”, but:

„Which peptide, at what concentration, in what formulation and for what result was tested?”.

Skin appearance and tissue mechanisms are different types of claims

When testing creams, researchers often evaluate the visibility of fine lines, wrinkle roughness, skin surface structure, hydration, elasticity-related parameters, and perceived firmness.

Mechanistic studies, on the other hand, can analyse fibroblast responses, extracellular matrix proteins, collagen-related pathways, gene expression, signalling pathways or tissue biomarkers.

These are different levels of evidence.

A change in wrinkle geometry does not directly indicate which cells have altered their activity. On the other hand, a change in a biomarker in cell culture does not automatically mean a visible improvement in the skin following the simple application of a cosmetic product.

In GHK-Cu research combined with hyaluronic acid, collagen IV-related responses have been observed in fibroblasts and ex vivo skin experiments. [3] These data help investigate possible mechanisms, but are not equivalent to a controlled trial of a finished cream in humans.

They also do not confirm that regular use of any cream containing GHK-Cu and hyaluronic acid delivers the same amounts of the substances to the skin as those used in the experiment.

The most precise approach therefore consists in describing what was actually measured, rather than turning every positive result into a broad claim that the product „rebuilds the skin”.

Peptides and moisturising ingredients

Humectants, emollients and occlusive substances perform different functions

Moisturising preparations contain ingredients with various formulation functions and skin-related properties.

Humectants interact with water and can support the hydration of the formulation and the outer layers of the skin. Emollients influence softness, oiliness, smoothness and sensory properties. Occlusive substances, on the other hand, can limit water loss by forming a more resilient layer on the skin's surface.

These categories are useful, but not always entirely mutually exclusive. A single ingredient or an entire formulation can perform several functions simultaneously.

Peptides are something else. The word „peptide” describes a broad chemical group, not a single universal moisturising mechanism. A specific peptide may be studied for signalling or another biological interaction, while the cream surrounding it accounts for a significant part of the immediate moisturising effect.

These categories describe potential functions of the ingredients, rather than ranking them. The performance of the finished cream depends on the entire formulation system.

The cream base should not be treated as biologically inactive

Describing a cream base as a „vehicle” might suggest that it does nothing on its own. That is not necessarily the case.

That is precisely why a well-chosen substrate control is so valuable in cosmetic testing.

In the study of petrolatum, the skin of 36 healthy participants and 13 individuals with atopic dermatitis was analysed using molecular and structural measurements. Under specific experimental conditions with occlusion, petrolatum influenced markers associated with epidermal differentiation and the innate response compared with the controls applied. [4]

This does not mean that every moisturiser elicits the same response. Nor should the experimental conditions be automatically equated with the ordinary use of every cosmetic product.

The conclusion is significant, however: a commonly used ingredient in moisturisers can itself cause measurable changes in the skin.

Therefore, the improvement observed after applying the complex peptide cream should not be automatically attributed to the peptide highlighted on the label.

Instead of a simple split between „active peptide” and „inactive cream”, it is worth asking: what did the complete formulation do and what additional effect can be attributed to the peptide, if the study design actually allows this to be distinguished?

Hydration and transepidermal water loss are different measurements

Skin hydration and transepidermal water loss are related to its condition, but they do not mean the same thing.

Hydration measurement assesses properties related to the water content in the outer layers of the skin under specific test conditions. Transepidermal water loss, referred to as TEWL, measures the flow of water through the skin under given conditions.

Improvement of one parameter does not automatically mean an equivalent improvement of the other. Neither of these measurements on its own confirms the formation of new collagen, dermal remodelling, the permanent restoration of the barrier, or the inhibition of biological skin ageing.

Environmental conditions are also important. Temperature, humidity, acclimatisation time, recent skin washing, prior application of cosmetics and the measurement technique can influence certain results.

In a small randomised study comparing two peptide creams with a placebo, hydration, TEWL, skin mechanical properties, photographs and the crow's feet wrinkle scale were evaluated. [5]

The use of multiple measurements shows an important principle: „skin improvement” is not a single scientific endpoint.

The study involved 21 Indonesian women observed over eight weeks. The results should therefore be treated as data from a small controlled experiment, rather than as a definitive ranking applicable to all populations and all commercial formulations.

Combining multiple ingredients makes it difficult to attribute the effect

Peptide creams often also contain niacinamide, retinoids, hyaluronic acid, ceramides, antioxidants, exfoliating ingredients, plant extracts, humectants or occlusive substances.

Such combinations can be useful formulation-wise and cosmetically. However, a positive result from testing the whole formulation does not indicate the contribution made by each of its ingredients, unless the experimental design was specifically set up to separate them.

Research on a retinaldehyde serum also containing peptides, ceramides and lipids shows the same problem of effect attribution in a different cosmetic format. [6] The ready-made combination was studied, not the peptides in isolation.

The same principle applies to a cream with multiple potentially active ingredients. Without adequate controls, the result must be attributed primarily to the complete formulation tested.

Even laboratory evidence of an interaction between two ingredients should not automatically be turned into a claim of clinical synergy. Findings regarding GHK-Cu and hyaluronic acid in cells and ex vivo skin support research into their mutual biological interaction. [3] However, they do not prove that every moisturising preparation containing both ingredients delivers a synergistic clinical effect.

Ingredient name is not a quantitative specification

The ingredient list helps to determine what is in the formulation, but it does not have to reveal the exact concentration, the amount of pure peptide, the content of the patented peptide complex, the purity of the peptide, or its stability throughout the product's shelf life.

Commercial peptide raw material may itself be a mixture containing the peptide, water, solvents, stabilisers or other substances. Therefore, the percentage given alongside the name of a „peptide complex” should not be automatically interpreted as the same percentage of pure peptide.

To determine the actual content, an appropriate analytical method is needed. In studies on palmitoyl peptides in cosmetics, LC-MS/MS was used to analyse the peptide content in cosmetic matrices. [7]

This shows a significant difference between identifying an ingredient on a label and quantitative chemical measurement.

However, an analysis of the composition does not, in itself, complete the entire chain of evidence. The peptide may be present in the cream, but there may still be a lack of data confirming its stability over time, its delivery to the proposed biological target, or its independent contribution to the observed cosmetic effect.

Identity, quantity, stability, delivery, mechanism and clinical effect are interrelated, but remain separate questions.

Creams versus serums containing peptides

Consistency describes the product, but not its potency

Creams are generally more semi-solid than serums, whilst many serums come in the form of liquids or gels. However, these categories do overlap to some extent. A serum may be an emulsion, and a cream may have a very light texture.

The product name alone does not specify the water-to-oil ratio, the concentration or number of peptides, the degree of occlusion, the depth of penetration, or the efficacy.

Differences in texture can affect spreadability, the film left behind, comfort during use, the ability to apply further products, user preferences and the regularity of application. These are practically significant characteristics, but they do not provide a direct measure of the peptide’s activity.

A detailed discussion of the second of these categories can be found in the article Peptide serum: ingredients, claims and scientific evidence.

A scientifically valid comparison should start with the actual formulations. Otherwise, the phrase „cream versus serum” may mask a number of simultaneous differences.

A more concentrated product does not mean that the peptide is delivered more deeply

The cream may alter the environment on the skin’s surface and affect water loss. However, this does not prove that the peptide it contains reaches the living epidermis or dermis.

Similarly, the lighter texture of the serum does not necessarily mean it penetrates better.

Peptide delivery may depend on the molecule’s size, charge, hydrophilicity, lipophilicity, chemical modifications, the type of substrate, the condition of the skin and the experimental conditions.

A review on acetyl hexapeptide-8 discusses permeability limitations and uncertainty regarding access to sites related to the proposed mechanism of action on neurotransmission. [8] This demonstrates why delivery cannot be inferred from consistency alone.

When assessing claims regarding penetration, it is necessary to establish which substance was measured, whether it remained chemically intact, where it was detected and — ideally — in what quantity.

The skin surface, the stratum corneum, the living epidermis and the dermis are different locations. The detection of a peptide in the stratum corneum does not mean that it has reached the dermis.

The method developed for the quantification of hexapeptides in matrices used in skin research can assist in the analysis of their distribution within individual skin layers. [9] However, the validation of the method alone does not prove that the finished commercial cream achieves the proposed level of penetration.

Detectable penetration does not always indicate a biologically significant delivery

Modern analytical techniques can detect very small amounts of substances. Therefore, the mere detection of a peptide within the skin does not yet mean that a sufficient quantity has reached the target to produce the claimed effect.

A more complete mechanistic chain might look like this:

the peptide is in the cream → it remains chemically stable → the intact molecule crosses the relevant barrier → a sufficient concentration reaches the target → a biological response occurs → a significant effect is observed in humans.

Individual studies may analyse different stages of this chain.

A controlled human clinical trial can confirm an improvement in skin appearance even when all stages of the mechanism have not been demonstrated. However, if a product contains a specific claim regarding deep delivery or molecular action, evidence concerning intermediate stages becomes particularly relevant.

The combined use of a serum and a cream does not prove the superiority of such a combination

The study may assess the serum and cream used together, without determining which of them works better. Such a design evaluates the entire routine.

A 12-week study analysed a hyaluronic acid serum and a peptide-rich cream used simultaneously on the face and neck. The study was completed by 17 people, and the authors reported an improvement compared with baseline values and good tolerability. [10]

However, the project did not make it possible to determine the independent effect of the cream, the independent effect of the serum, the superiority of the cream over the serum, the superiority of the serum over the cream, or whether the combination of both products was more effective than either used alone.

To answer such questions, appropriate comparison groups are needed.

Similarly, one cannot compare the percentage improvement from a single cream study with a percentage result from an independent serum study and determine on this basis which format is more effective. The studies may differ in terms of population, initial severity of lesions, measurement scale, duration, comparator, product formulation, and statistical methods.

Stability depends on the entire formulation and packaging.

The physical appearance of the product does not confirm its chemical stability.

The cream can maintain its expected colour, consistency, scent and structure, even though one of the ingredients undergoes a chemical change.

Stability can be affected by oxygen, light, temperature, pH, water activity, interactions between ingredients, packaging and storage time.

An analytical study on acetyl hexapeptide-8 analysed the peptide and its oxidised form in cosmetic products, highlighting issues related to chemical characterisation and sample preparation. [11]

This does not mean that every peptide cream undergoes significant oxidation or that a specific type of packaging prevents it. The conclusion is narrower: peptide stability must be assessed in the actual formulation and under appropriate storage conditions.

Packaging may matter, but it does not prove superiority

Jars, tubes, pumps and airless systems differ in how the product is exposed to air, contact with fingers, repeated opening, light and environmental conditions.

These differences may be important when designing formulations, but the mere presence of an airless pump does not confirm better stability of the peptide.

To demonstrate the superiority of a specific packaging, it would be necessary to properly test the complete product-packaging system under appropriate conditions.

Packaging can support stability. However, it does not replace stability data.

Day and night peptide creams

„For day” and „for night” primarily describe the intended use

A day cream can be designed with a lighter texture, makeup compatibility, less residual film or sun protection functions. A night cream may have a richer texture or contain ingredients selected for evening use.

These are common formulation decisions, but they do not constitute universal scientific definitions.

The terms „day” and „night” do not create two different classes of peptides. A peptide does not become a different molecule just because it has been added to a night cream.

Similarly, application in the evening does not automatically mean greater biological activity.

To demonstrate that the time of application alters the effectiveness of a peptide cream, one would need to compare the relevant time conditions while controlling for other significant variables.

The discussed research does not provide a direct comparison between morning and evening application of the identical peptide cream. This is a limitation of the available evidence, which should not be replaced by assumptions.

The study schedule does not indicate the best time of administration

The application schedule used in the clinical trial defines the exposure investigated in the given experiment. It does not prove that such a schedule is better than all alternatives unless they have been directly compared.

For example, an eight-week randomised trial of peptide creams evaluated products according to a specific schedule. [5] The aim was to compare the effects of the formulations rather than to determine whether morning application is more effective than evening application.

Similarly, observing changes after using a night product does not prove that the time of application alone was responsible for the effect.

The question „how to apply a peptide cream?” therefore requires the context of a specific product. The broad category of peptides does not dictate a single scientifically established frequency, amount, order of application, or best time of day for all formulations.

The presence of the peptide does not imply sun protection

A daytime peptide cream does not automatically provide significant protection against ultraviolet radiation.

The presence of the peptide does not determine SPF, UVA protection, UVB protection or broad-spectrum action. These properties require appropriate testing specific to sun protection products.

The FDA explains that SPF refers to protection against sunburn in a specific test, whereas the „broad spectrum” designation relates to protection across the UVA and UVB ranges. [12]

These are separate issues from anti-wrinkle, peptide, antioxidant or moisturising action.

Therefore:

day cream ≠ sunscreen

and

presence of peptide ≠ SPF.

A single product can, of course, combine a moisturising function, peptide ingredients and sun protection, but each of these functions requires appropriate evidence.

The differences between day and night creams can result from different ingredients

Day and night creams belonging to the same range can differ by more than just the time of application.

They may contain other humectants, lipids, retinoids, antioxidants, fragrances, preservatives, texture modifiers, or peptide concentrations.

If the product effects are different, it cannot be automatically assumed that the time of application was the cause.

Research into a formulation containing retinaldehyde, peptides and lipids shows why a multi-ingredient product intended for evening use should be evaluated as a whole. [6]

Without appropriate comparison groups, the result does not isolate the effect of the peptide, retinaldehyde, the base, or the nighttime hours themselves.

Similarly, terms such as „night repair” require definition. „Regeneration” can mean improved hydration, lower TEWL, a smoother appearance of the skin, a change in a biomarker, or a proposed biological pathway.

Without specifying a concrete measurement, such a term is too broad to describe a confirmed mechanism.

How to evaluate tests of ready-made creams?

Properly selected substrate helps determine the additional contribution of the peptide

In a controlled study, the formulation containing the analyzed component is compared with a corresponding control without that component.

This allows for a better distinction between the effects of the moisturizing product itself and the additional effect associated with the peptide.

A good example is the pal-KTTKS study [2]. The participants received the same moisturizing preparation with and without the peptide on opposite sides of their faces.

Randomization and blinding limited several potential sources of error, so the project provides stronger evidence regarding a specific peptide than an uncontrolled study in which participants simply apply a complex cream and compare the later skin condition with the initial one.

Even well-conducted controlled-release studies remain specific to the peptide under study, its concentration, formulation, population, duration, and endpoints. They do not automatically confirm all products containing the same ingredient.

The substrate does not have to be biologically inert in order to provide good control.

An important point is that the control base does not have to do „nothing”.

Moisturizers themselves can have an effect on the skin — which is why their use as a control is so valuable.

If both sides of the face receive the same moisturizing base, but only one contains a peptide, the difference between them can provide information about the additional contribution of the peptide.

This is particularly important in wrinkle research, because hydration itself can affect their appearance.

Without proper control of the substrate, assigning the observed effect to a peptide becomes much more difficult.

Small studies are valuable but not conclusive

In a randomized, double-blind study from 2023, 21 Indonesian women were compared with acetylhexapeptide-3 cream, palmitoyl pentapeptide-4 cream, and placebo for eight weeks. [5]

The researchers described more favorable results for the formulation containing the palmitoyl pentapeptide and indicated the need for larger and longer studies.

A small sample size means that the results should not be used to rank all palmitoylated peptides, all acetylated peptides, or any commercial product containing these ingredients.

In another 12-week study involving 25 women, tetrapeptide-68 was administered in an oil-in-water formulation. Changes in wrinkles were observed using three-dimensional surface analysis and questionnaires. The publication describes the study as randomized, double-blind, and placebo-controlled. [13]

This represents another valuable controlled signal, but the small number of participants and the limited time still do not allow for broad conclusions regarding the durability of the effects, rare reactions, diverse populations, or all products containing tetrapeptide-68.

Read first what was measured, and only then the headline

The cream test can analyze many different results, each of which must be interpreted according to what it actually represents.

The consistency of several appropriate measurements can strengthen the interpretation, but the design of the study should still be taken into account.

It is worth paying attention to the magnitude of the effect, the statistical uncertainty, the initial magnitude of the changes, the reliability of the measurement, the response of the control group, and whether the result was compared with the control group or only with the initial state.

The percentage of improvement requires a clear reference point

The statement „the wrinkles have improved by 40%” is incomplete without information about what exactly the percentage refers to.

It can mean a change in the average score, the area of wrinkles, their depth, the investigator's assessment, the participants' responses, or the percentage of people reaching a previously set threshold.

These are different sizes.

For example, if the numerical result drops from five to three, it means a reduction of that result by 40%. This does not mean that „40% years of skin aging have been reversed”.

If the control group also improves significantly, the difference attributed to the product being tested may be significantly smaller than the percentage of change observed within the group.

In the study of serum used together with a cream, an improvement was reported compared to the initial values.[10] Such percentages should therefore not be presented as an advantage over placebo or other moisturizing preparations.

The indication of the correct reference point retains the scientific significance of the number.

Statistical significance and practical importance are two different questions

A statistically significant difference means that the result met the statistical criteria set in the study. It does not automatically indicate whether the difference is large, visible, important to the user, or lasting.

On the other hand, the satisfaction of the participants can provide valuable information about the actual use of the product, but it can also depend on its consistency, fragrance, packaging, immediate moisturizing effect, or expectations.

A reliable interpretation should therefore take into account both objective measurements and the practical magnitude of the observed difference.

The conclusions regarding tolerance depend on the population and the length of observation period.

The cream may be well tolerated in the study, but that does not mean it will be suitable for everyone.

Clinical studies may not be conducted in people with certain skin diseases, known hypersensitivities, active irritation, allergies, or other problems.

Small trials also have limited ability to detect rare reactions.

The lack of adverse effects in the study with tetrapeptide-68 is significant with regard to the participants and the observation period. [13] However, it does not prove the universal suitability for sensitive skin, all age groups, any skin disease, or use for an unlimited period of time.

The other ingredients of the formulation are also important.

Proposed computational models regarding the safety of cosmetic peptides can help researchers identify potential hazards and questions that require further analysis. [14] However, these predictions do not replace data regarding the finished product.

Evidence regarding the product should remain associated with the product under investigation

The study may provide valuable evidence regarding one cream, while leaving significant uncertainty regarding another product containing the same peptide.

The differences may relate to the concentration of the peptide, the excipient, the pH, other active ingredients, stability, packaging, the amount of product applied, or the frequency of use.

The most defensive scientific description therefore combines:

material + formulation + study design + comparator + result + limitations.

A controlled study on wrinkles can support the proposal to change specific wrinkle parameters under given conditions. A study of the entire routine provides information about that routine. Chemical analysis can characterize the content or stability of the peptide, and laboratory experimentation supports the proposed mechanism.

These types of evidence can be complementary, but they are not interchangeable.

Practical checklist for evaluating a peptide cream

Before accepting the claim regarding a cream or moisturizing product with peptides, it is worth checking:

1. What exactly is the peptide contained in the product?

The term „contains peptides” provides much less information than the specific name of the ingredient.

2. Is its concentration known?

If a percentage value has been given, it must be determined whether it refers to a pure peptide or a larger complex of components.

3. What else is in the cream?

Humectants, retinoids, ceramides, niacinamide, hyaluronic acid, and other substances can affect the same parameters that are highlighted in the product communication.

4. Was the finished cream tested?

Studies of a single component do not automatically confirm the effectiveness of a finished formulation.

5. Was a corresponding control substrate used?

A similar formulation without the peptide can help determine its additional contribution.

6. Was the result compared to the initial state, or with the control?

These are different levels of evidence.

7. What exactly was measured?

Moisture content, TEWL, wrinkle depth, elasticity, collagen biomarkers, and user satisfaction are not equivalent results.

8. Does the proposed mechanism require penetration into the skin?

If so, it is worth checking whether the delivery to the appropriate layer has actually been demonstrated.

9. How many people participated in the study and how long did it last?

Small, short-term studies should not be turned into universal or lasting claims.

10. Does the marketing message go beyond the experiment?

The strongest interpretation remains close to what the researchers actually measured.

Frequently asked questions

1. Do peptide creams differ from peptide serums?

They may differ in physical structure, consistency, moisturizing system, lipid content, occlusive properties, and user experience, but the terms „cream” and „serum” themselves do not define the standard difference in the potency of peptides. Creams are often semi-solid emulsions, whereas serums can take the form of lighter liquids, gels, or emulsions. A study in which serum and cream were used together did not compare their independent effects. [10] Therefore, a scientifically valuable comparison should focus on the actual formulations, identity, and concentration of peptides, the type of vehicle, and the results of the studies, rather than the assumption that one format is inherently more effective.

2. Does the word „peptide” itself confirm the effectiveness of the cream?

No. „Peptide” refers to a broad chemical category and does not prove the efficacy of a ready-made cream. Individual peptides have different sequences, structures, modifications, concentrations, and proposed biological activities, and their behavior also depends on the surrounding formulation. Controlled testing of palmitoyl pentapeptide supports a specific formulation and a specific comparison, not all products labeled as peptide creams. [2] Therefore, a reliable claim regarding efficacy should be linked to a specific product with an appropriately measured result.

3. Can a peptide cream moisturize primarily thanks to other ingredients?

Yes. Humectants, emollients, occlusive agents, and other base ingredients can significantly influence the hydration, softness, lubrication, and appearance of the skin surface. A peptide does not necessarily account for every observed moisturizing effect. A study of vaseline in humans showed that even a component often perceived as a substrate can, under certain conditions, elicit measurable skin responses.[4] These results should not be directly applied to any cream, but they do show why the base of a formulation is important. Assigning a specific effect to a peptide requires proper comparison.

4. Are peptides the same as ceramides or hyaluronic acid?

No. Peptides, ceramides, and hyaluronic acid belong to different chemical groups and can perform different functions in cosmetics. Their simultaneous presence does not mean that they are interchangeable or that they automatically work synergistically. In the GHK-Cu and hyaluronic acid study, results related to collagen IV were observed in cells and skin ex vivo [3]. This provides mechanistic information about the specific experimental system, but does not prove that any cream containing both ingredients produces the same effect in humans.

5. Is a rich peptide cream more effective than a light one?

No. The „rich” consistency describes primarily the formulation and sensory properties, not the standard measure of peptide activity. A thicker cream may contain more oils, occlusive ingredients, polymers, or other substances, without, however, containing more peptide or causing a stronger effect associated with the peptide. The science of moisturizing preparations shows that the base can influence the skin properties and the behavior of other ingredients.[1] However, this does not create a simple scale of effectiveness based on consistency. For comparison, data on actual formulations are needed.

6. Does the occlusive effect of the cream mean that the peptide reaches deeper?

No. Limiting the loss of water on the surface of the skin does not prove that the intact peptide reaches the living epidermis, dermis, or other proposed biological target. Delivery depends on the properties of the molecule, formulation, skin barrier, and experimental conditions. Methods developed for the quantitative determination of hexapeptides in various skin matrices show why the distribution of the component must be measured directly.[9] Even detecting it in the outer layer of the skin does not mean sufficient exposure at the deeper target site.

7. Does the improvement in hydration mean that the peptide cream has repaired the skin barrier?

Not necessarily. Moisture and the function of the skin barrier are related, but they remain different concepts. Measurements of moisture and TEWL analyze different properties, and a broad claim of „barrier repair” may require additional data. In a small study of three groups of peptide creams, moisture, water loss, mechanical properties, photographs, and the appearance of wrinkles around the eyes were evaluated separately. [5] The most precise description should therefore indicate a specific parameter that changed, rather than automatically converting the improvement in moisture into full regeneration of the barrier.

8. Are night peptide creams more effective than day creams?

The evidence discussed does not confirm that night-time peptide creams are generally more effective than day-time products. Demonstrating a specific benefit would require a proper comparison, preferably of similar formulations used at different times of day. The studies cited concerned specific products and regimens, not a controlled comparison of morning and evening applications. [2] [5] Therefore, the term „for night time use” should be considered primarily as information about the intended method of use or positioning of the product, unless a suitable study confirms something more.

9. Does the day cream peptide automatically provide sun protection?

No. The presence of peptides or the designation of the product as daily does not confirm SPF, UVA, UVB protection, or broad-spectrum action. Such properties require studies characteristic of sunscreen filters. The FDA distinguishes sunburn protection associated with SPF from broad-spectrum protection that includes UVA and UVB radiation. [12] Evidence regarding the effect of a peptide cream on wrinkles or hydration does not constitute proof of sunscreen protection. One product may combine several functions, but each requires appropriate confirmation.

10. Does the application scheme used in the study indicate the best way to use all the peptide creams?

No. The scheme used in the study specifies the way exposure to a specific formulation is achieved in this experiment. To determine the optimal frequency or timing of application, it would be necessary to compare the appropriate alternatives. A randomized study of two peptide creams and a placebo examined the efficacy of the formulations, not the universally best timing or frequency of application. [5] The manufacturer's instructions also refer to a specific product. Neither a single study nor the peptide category itself establishes a scientifically validated scheme for all creams.

11. Does the use of serum and peptide cream together provide a proven additional benefit?

This cannot be assumed. Demonstrating an additional benefit requires comparing the entire combination with corresponding variants that include a single product or the same routine without the additional cosmetic product. In the 12-week study, both the hyaluronic acid serum and the peptide-rich cream were used simultaneously, and the participants were compared primarily based on their baseline condition. [10] Therefore, it cannot be determined whether both products were necessary, which had a greater effect, or whether their combination was better than each of them used separately.

12. Why is the same cream without a peptide a valuable control?

This allows for a better separation of the effect of the moisturizing base itself from the additional effect associated with the peptide. This is important because the base can itself influence hydration, softness, smoothness, and the visibility of fine lines. In the pal-KTTKS study, the same moisturizing formulation with and without the peptide was used in a randomized split-face study. [2] This reinforces the possibility of attributing the difference to the additional peptide within a specific comparison. However, the result still applies to the tested peptide, formulation, population, time, and measured parameters.

13. Does a positive study regarding wrinkles prove the production of new collagen?

No. Reducing depth, roughness, or other wrinkle parameters is not in itself evidence of new collagen synthesis. Imaging and clinical scales describe primarily the visible or superficial result. In the tetrapeptide-68 study, wrinkle parameters were evaluated, among others, using three-dimensional surface analysis. [13] These results should not be automatically interpreted as evidence of collagen synthesis or confirmation of all proposed molecular mechanisms. Claims regarding collagen require appropriate measurements related specifically to collagen.

14. Is it possible to directly compare percentages from different studies of creams and serums?

Usually not. Percentages are comparable only when their definitions, endpoints, populations, initial severity of changes, duration, and comparators are appropriately similar. The percent improvement over baseline is not the same as the percent advantage over the baseline. In the cream serum study, changes were primarily reported relative to baseline values, whereas the pal-KTTKS study included the corresponding control formulation. [10] [2] Therefore, it is not possible to simply compare the percentages from both publications and use them to create a ranking of products or formats.

15. Does the airless pump guarantee the stability of the peptide cream?

No. The airless system can reduce the exposure of formulations to air and contact during use, but the packaging itself does not confirm chemical stability over the entire shelf life. The full composition, packaging, storage conditions, temperature, light, and appropriate chemical changes must be taken into account. Acetyl hexapeptide-8 studies regarding oxidation, among others, show why the actual chemical state of the ingredient may matter. [11] However, they do not establish a universal ranking of packaging. A claim of greater stability requires data regarding a specific product.

16. Are peptide creams automatically suitable for sensitive skin?

No. Tolerance depends on the complete formulation, the tested population, the conditions of use, and the duration of exposure. The product may contain fragrance substances, preservatives, retinoids, exfoliating ingredients, plant materials, or other substances that affect tolerance independently of the peptide. In the study involving tetrapeptide-68 and 25 participants, no adverse reactions were reported during the observation period. [13] This is information regarding this population and this time period, but it does not prove the universal suitability for every person with sensitive skin or for all peptide creams.

17. What evidence best supports the effectiveness of a specific peptide cream?

The most direct information is provided by a well-described human study of a real finished cream, with an appropriate control group, clearly defined results, and sufficient methodological information. If the question concerns the additional contribution of a peptide, a comparison with a counterpart without this peptide is particularly valuable, as in the pentapeptide palmitoylethyl acetate study. [2] However, even strong results should remain linked to the studied formulation, population, duration, and specific endpoint.

18. Does more peptide mean a better cream?

Not necessarily. Higher concentrations do not necessarily mean a stronger clinical effect, and different peptides cannot be compared solely on the basis of percentages. They may differ in sequence, modifications, stability, formulation behavior, and potential biological targets. The declared percentage may also refer to the entire peptide complex rather than just the pure peptide. Chemical analysis can determine the content, but the content alone does not confirm delivery or efficacy. [7] For meaningful comparison, information about the specific peptide, concentration, formulation, and relevant studies are needed.

19. Can two creams containing the same peptide work differently?

Yes. Two products with the same named peptide may differ in their concentration, base, pH, stability, additional ingredients, packaging, and conditions of use. All these elements can affect the performance of the finished product and the possibility of transferring the results of the tests from one formulation to another. Therefore, evidence from a controlled study of one cream should not be automatically attributed to all products containing the same peptide. The more similar the second formulation and its method of use are, the more suitable the data may be, but equivalence should still not be assumed without additional information.

20. Does the detection of the peptide in the skin prove that the cream is effective?

No. The detection of a peptide in the skin can provide valuable information regarding its delivery, but by itself it does not confirm clinical efficacy. It remains to be determined whether the intact peptide is detected in the layer where it is located, in what quantity, whether the achieved concentration has a biological significance, and whether the proposed effect occurs. Analytical methods that enable the detection of hexapeptides in various skin matrices provide tools for studying their distribution. [9] The clinical efficacy remains a separate question requiring evidence appropriate to the specific effect in humans.

Limitations of evidence regarding creams and moisturizing preparations with peptides

„Peptide cream” describes a broad category rather than a single standardized intervention. Products can contain completely different peptide sequences, concentrations, chemical modifications, carriers, and additional ingredients.

The moisturizing base itself can have significant effects. Changes in moisture levels, softness, water loss, or the appearance of the skin’s surface should not therefore be automatically attributed to the peptide.[1][4]

Multicomponent formulations further complicate the determination of the contribution of individual substances. If a cream contains peptides along with retinoids, niacinamide, ceramides, hyaluronic acid, or other active ingredients, a positive test primarily supports the entire formulation unless appropriate controls allow the individual components to be isolated. [3] [6]

Results regarding skin appearance and mechanistic data should remain separate. The reduction in wrinkle roughness does not in itself indicate collagen synthesis, and the collagen-related response observed in cells does not automatically mean a visible improvement after topical application.[3]

Penetration of the peptide should also not be inferred based on consistency, formulation richness, occlusion, or packaging type. Delivery to the appropriate skin layer requires appropriate experimental data.[8][9]

Small studies may provide useful signals, but they do not confirm a universal effect. Experiments involving 21 or 25 people should be interpreted in the context of their size, population, and duration.[5][13]

Comparison with the initial state is not equivalent to a controlled study under appropriate conditions. The improvement after several weeks of using the product does not show what part of the change would occur after using the cream base itself or another appropriate control.

The terms „for the day” and „for the night” also do not confirm the time-dependent activity of the peptide. Direct studies comparing the time of application would be needed to reach this conclusion.

It is also not advisable to create rankings based on percentage results derived from independent studies without checking the reference points, comparators, scales, populations, and methods.

Ultimately, the evidence should remain specific to the formulation. A study of one peptide cream does not automatically confirm the effectiveness of all moisturizing products containing the same peptide.

Summary

Creams and moisturizing preparations containing peptides combine two important elements: a complete moisturizing formulation and one or more peptide ingredients. Proper interpretation of the studies requires taking both of these elements into account.

Humectants, emollients, occlusive ingredients, lipids, emulsifiers, and other substances can affect hydration, softness, water loss, skin surface appearance, and sensory properties regardless of the peptide. At the same time, some specific peptides have been studied for additional biological or skin appearance-related effects.

Controlled human studies provide useful data regarding certain specific formulations. The pal-KTTKS study is particularly informative because it compared the same moisturizing preparation with and without the peptide in a randomized, double-blind split-face study. [2]

Smaller controlled studies of other peptide creams provide additional data, but they remain limited in terms of sample size, duration, and the specific formulation being studied.[5][13]

The wider body of evidence also shows why it is worth avoiding several common simplifications:

rich cream ≠ stronger peptide effect;

serum ≠ automatically better penetration;

occlusive cream ≠ confirmed delivery of the peptide to the epidermis;

night cream ≠ increased peptide activity;

day cream ≠ sunscreen;

a higher percentage of peptide ≠ greater effectiveness;

improvement of the appearance of wrinkles ≠ automatic evidence of collagen synthesis;

improvement after the use of the finished product ≠ isolated effect of the peptide.

The strongest interpretation combines the specific peptide and the ready-made formulation with the study design, the comparator used, the actually measured result, and the limitations of the available evidence.

This approach allows us to evaluate peptide creams without rejecting the actual results of the studies, but also without extending them beyond what has actually been demonstrated.

Disclaimer

The article is purely educational and scientifically informative. It discusses peptide cosmetic ingredients, formulations of moisturizing preparations, skin measurements, analytical studies, issues related to the delivery of ingredients, and human-based cosmetic studies.

It does not constitute medical or dermatological advice, diagnosis, treatment recommendations, or recommendations for the purchase or use of a specific peptide cream, moisturizing product, serum, or other cosmetic product.

Results regarding a single peptide, formulation, concentration, study population, or skincare routine should not be automatically transferred to other products. Individuals with persistent skin problems, significant irritation, known allergies, or other dermatological issues should consult with an appropriately qualified specialist.

References

1. Draelos, Z. D. (2018). The science behind skin care: Moisturizers. Journal of Cosmetic Dermatology, 17(2), 138–144. https://doi.org/10.1111/jocd.12490
2. Robinson, L. R., Fitzgerald, N. C., Doughty, D. G., Dawes, N. C., Berge, C. A., & Bissett, D. L. (2005). Topical palmitoyl pentapeptide provides improvement in photoaged human facial skin. International Journal of Cosmetic Science, 27(3), 155–160. https://doi.org/10.1111/j.1467-2494.2005.00261.x
3. Jiang, F., Wu, Y., Liu, Z., Hong, M., & Huang, Y. (2023). Synergy of GHK-Cu and hyaluronic acid on collagen IV upregulation via fibroblast and ex-vivo skin tests. Journal of Cosmetic Dermatology, 22(9), 2598–2604. https://doi.org/10.1111/jocd.15763
4. Czarnowicki, T., Malajian, D., Khattri, S., Correa da Rosa, J., Dutt, R., Finney, R., Dhingra, N., Xiangyu, P., Xu, H., Estrada, Y. D., Zheng, X., Gilleaudeau, P., Sullivan-Whalen, M., Suaréz-Fariñas, M., Shemer, A., Krueger, J. G., & Guttman-Yassky, E. (2016). Petrolatum: Barrier repair and antimicrobial responses underlying this „inert” moisturizer. Journal of Allergy and Clinical Immunology, 137(4), 1091-1102.e7. https://doi.org/10.1016/j.jaci.2015.08.013
5. Aruan, R. R., Hutabarat, H., Widodo, A. A., Firdiyono, M. T. C. C., Wirawanty, C., & Fransiska, L. (2023). Double-blind, randomized trial on the effectiveness of acetylhexapeptide-3 cream and palmitoyl pentapeptide-4 cream for crow’s feet. The Journal of Clinical and Aesthetic Dermatology, 16(2), 37–43. https://pubmed.ncbi.nlm.nih.gov/36909866/
6. Konisky, H., Bowe, W. P., Yang, P., & Kobets, K. (2024). The clinical efficacy and tolerability of a novel retinaldehyde serum with firming peptides to improve skin texture and signs of photoaging. Journal of Drugs in Dermatology, 23(11), 992–997. https://pubmed.ncbi.nlm.nih.gov/39496127/
7. Chirita, R. I., Chaimbault, P., Archambault, J. C., Robert, I., & Elfakir, C. (2009). Development of a LC-MS/MS method to monitor palmitoyl peptides content in anti-wrinkle cosmetics. Analytica Chimica Acta, 641(1–2), 95–100. https://doi.org/10.1016/j.aca.2009.03.015
8. Zdrada-Nowak, J., Surgiel-Gemza, A., & Szatkowska, M. (2025). Acetyl hexapeptide-8 in cosmeceuticals—A review of skin permeability and efficacy. International Journal of Molecular Sciences, 26(12), Article 5722. https://doi.org/10.3390/ijms26125722
9. Zhou, W., Wang, P. G., Ogunsola, O. A., & Kraeling, M. E. (2013). Rapid determination of hexapeptides by hydrophilic interaction LC-MS/MS for in vitro skin-penetration studies. Bioanalysis, 5(11), 1353–1362. https://doi.org/10.4155/bio.13.60
10. Gold, M. H., Biron, J. A., Wilson, A., & Nelson, D. B. (2022). Efficacy and tolerability of a hyaluronic acid-based serum and a peptide-rich cream for the face and neck in subjects with photodamaged skin. Journal of Cosmetic Dermatology, 21(8), 3458–3463. https://doi.org/10.1111/jocd.14981
11. Kluczyk, A., Ludwiczak, J., Modzel, M., Kuczer, M., Cebrat, M., Biernat, M., & Bąchor, R. (2021). Argireline: Needle-free Botox as analytical challenge. Chemistry & Biodiversity, 18(3), Article e2000992. https://doi.org/10.1002/cbdv.202000992
12. U.S. Food and Drug Administration. (n.d.). Sunscreen: How to help protect your skin from the sun. Retrieved September 20, 2026, from Sunscreen: How to help protect your skin from the sun
13. Lee, S. G., Kang, S. M., & Kang, H. (2024). Reduction of wrinkles using tetrapeptide-68 contained in an O/W formulation: A randomized double-blind placebo-controlled study. Pharmaceutics, 16(8), Article 987. https://doi.org/10.3390/pharmaceutics16080987
14. Bjerke, D. L., Li, J., Gao, Y., Hu, P., Lintner, K., & Hakozaki, T. (2026). A framework for the safety evaluation of peptides in cosmetics. Current Research in Toxicology, 10, Article 100291. https://doi.org/10.1016/j.crtox.2026.100291